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Given the fact that people spend 85–90% of
their time indoors (1), it is widely recognized
that a significant portion of total personal
exposures to particulate matter (PM) occurs
in indoor environments. Indoor particles are
composed of both ambient particles, which
inﬁltrate indoors, and nonambient particles,
which are generated indoors during the daily
activities of home occupants. In a previous
paper (2), we demonstrated that indoor ﬁne
particle concentrations in nine Boston-area
study homes were signiﬁcantly elevated dur-
ing cooking, cleaning, and other general
indoor activities involving combustion (e.g.,
burning candles) or physical movement
(e.g., walking). Indoor source events were
typically of short duration, but many were of
very high intensity, capable of raising hourly
concentrations of PM2.5 (particulate matter
≤ 2.5 µm in aerodynamic diameter) by tens
to hundreds of micrograms per cubic meter.
Furthermore, this and other studies have
shown that indoor particle events can sub-
stantially modify the size distribution and
composition of indoor particles (2–7).
Exposures to indoor-generated particles
may be highly relevant to public health
because of the high frequency of exposure to
large short-term events. In fact, concern over
the health signiﬁcance of exposures to peak
short-term concentrations has grown due to
the findings of several recent studies that
short-term ambient PM events are associated
with acute health outcomes (8–13). Due to
differences in size distributions and composi-
tion, it is possible that indoor-generated par-
ticles may be more or less toxic than ambient
particles. 
However, given the U.S. Environmental
Protection Agency’s (U.S. EPA) mandate to
regulate ambient air pollution, epidemio-
logic and toxicologic studies have tradition-
ally addressed only the health impacts of
ambient particles. Over 150 epidemiologic
studies have reported signiﬁcant associations
between ambient PM levels and excess mor-
tality and morbidity (14). Among the
adverse health outcomes that have been most
strongly linked to ambient PM exposures are
cardiopulmonary mortality, symptoms of
respiratory and cardiovascular disease, and
impaired lung function. Toxicologic studies
are ongoing to determine the causal agents
and underlying mechanisms for ambient PM
health effects (15,16). 
Due to their low cost and sensitivity, in
vitro toxicity tests are beginning to be used
more widely as exploratory tools in PM 
toxicologic studies. In vitro bioassays have
been more extensively used to investigate the
toxicologic properties of homogeneous parti-
cle mixtures including residual oil fuel ash,
urban air particles (UAP), inert titanium
dioxide, elemental carbon, and diesel parti-
cles (17–25). Only very recently have studies
reported bioassay data for ambient PM2.5
and PM10 samples. These studies have
demonstrated a variety of biological
responses for alveolar macrophages, blood
monocytes, and respiratory epithelial cells
including cytotoxicity, particle phagocytosis,
oxidant production, and production of
inflammatory mediators (21–23,26–28).
Speciﬁcally, these studies have provided evi-
dence that particle-bound endotoxin and
trace metals contribute to the observed bio-
logical activity of ambient PM samples. 
Despite the public health implications of
indoor particle exposures, only one of these
studies reported bioassay ﬁndings for indoor
particles (26). In this study, we used in vitro
bioassays to investigate the relative toxicity of
indoor and outdoor PM2.5 that was collected
from nine Boston-area homes as part of a
large indoor particle characterization study.
Similar to previous studies (23,29), the bioas-
says measured the tumor necrosis factor
(TNF) released by rat alveolar macrophages
(AMs) after exposures to indoor and outdoor
particles. We chose TNF as the measurement
end point because it is a potent proinﬂamma-
tory mediator in the lung that has been
shown to play a crucial role in the recruit-
ment and activation of numerous inﬂamma-
tory cells (30). To simulate preexisting
pulmonary inﬂammation such as that which
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In this study we assessed the in vitro toxicity of 14 paired indoor and outdoor PM2.5 samples
(particulate matter ≤ 2.5 µm in aerodynamic diameter) collected in 9 Boston-area homes. Samples
were collected as part of a large indoor particle characterization study that included the simultane-
ous measurement of indoor and outdoor PM2.5, particle size distributions, and compositional
data (e.g., elemental/organic carbon, endotoxin, etc.). Bioassays were conducted using rat alveolar
macrophages (AMs), and tumor necrosis factor (TNF) was measured to assess particle-induced
proinflammatory responses. Additional experiments were also conducted in which AMs were
primed with lipopolysaccharides (LPS) to simulate preexisting pulmonary inﬂammation such as
that which might exist in sick and elderly individuals. Signiﬁcant TNF production above that of
negative controls was observed for AMs exposed to either indoor or outdoor PM2.5. TNF releases
were further ampliﬁed for primed AMs, suggesting that preexisting inﬂammation can potentially
exacerbate the toxicity of not only outdoor PM2.5 (as shown by previous studies) but also indoor
PM2.5. In addition, indoor particle TNF production was found to be significantly higher than
outdoor particle TNF production in unprimed AMs, both before and after normalization for
endotoxin concentrations. Our results suggest that indoor-generated particles may be more bioac-
tive than ambient particles. Endotoxin was demonstrated to mediate proinﬂammatory responses
for both indoor and outdoor PM2.5, but study ﬁndings suggest the presence of other proinﬂam-
matory components of fine particles, particularly for indoor-generated particles. Given these
study findings and the fact that people spend 85–90% of their time indoors, future studies are
needed to address the toxicity of indoor particles. Key words: alveolar macrophage, cytokines,
endotoxin, fine particles, indoor air pollution, PM2.5, toxicity, tumor necrosis factor. Environ
Health Perspect 109:1019–1026 (2001). [Online 26 September 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1019-1026long/abstract.htmlmight exist in sick and elderly individuals, we
also conducted bioassays using macrophages
that were primed with lipopolysaccharides
before the particle exposures. 
Materials and Methods
Study design. As described previously, we
sampled nine nonsmoking Boston-area
homes for 1 or 2 week-long periods during
spring–summer and fall–winter 1998 (2). All
homes were located within 30 miles of
downtown Boston in suburban neighbor-
hoods. Study homes were typical of homes
in New England, a region in the United
States with four distinct seasons including
cold winters and warm summers. Windows
and doors were predominantly kept closed
for the winter months as well as the majority
of the spring and fall sampling periods.
During the winter months, ﬁve of the nine
homes were heated with oil, whereas the
remaining four had natural gas heating sys-
tems. Similarly, ﬁve homes had radiant heat
and four had forced-air heat. During the
summer months, home occupants typically
opened windows and doors to promote air
circulation. The major exception was Home
FOX1, which relied upon a central air-con-
ditioning system during the summer
months, including its July sampling event. 
Five of the nine study homes were sam-
pled during each of two seasons. All homes
were sampled a minimum of 6 consecutive
days on each sampling occasion, with most
homes sampled for at least 7 days and several
for longer periods. Table 1 summarizes the
locations, sampling dates, and sampling
duration for each study home.
Toxicity sample collection. Harvard
Impactors (HI; Air Diagnostics and
Engineering, Inc., Harrison, ME) were used
to collect indoor and outdoor PM2.5 samples
for the bioassays. To obtain a sufﬁcient mass
of particles, these samplers were operated
continuously for the duration of sampling at
each home. Hence, one indoor and one out-
door sample were collected during each
sampling period for a total of 14 indoor and
14 outdoor samples. 
PM2.5 HIs were operated at a ﬂow rate of
10 L/min according to previously documented
speciﬁcations (31,32). Flow rates were mea-
sured every 12 hr using calibrated rotometers,
and ﬂows were adjusted if they had changed
by more than ± 5%. Samples were collected
on preweighed 37-mm Teﬂon ﬁlters (Teﬂo;
Gelman Sciences, Ann Arbor, MI). All ﬁlters
were on- and off-weighed twice using a
Mettler MT-5 Microbalance (Mettler Toledo
International, Inc., Greifensee, Switzerland)
in a temperature- and relative humidity-
controlled weighing room after at least 48 hr
equilibration time. These weights were used
to determine ﬁlter loadings (Table 1).
Sample preparation and TNF bioassay.
Detailed laboratory methods describing sam-
ple preparation and the TNF bioassay have
been previously reported (21–23,28,33).
Briefly, we cut filters into tiny pieces and
placed them in a sterile, endotoxin-free
saline solution for sonication. The filter
pieces were removed after the sonication
procedure, and an aliquot of the suspension
was dried on a preweighed Teflo filter so
that the mass recovery from the ﬁlters could
be calculated (Table 1). Average percent
recoveries were 59 ± 6% (range 22–88%)
and 69 ± 7% (range 20–99%) for indoor
and outdoor samples, respectively. Neither
recoveries nor bioassay results are reported
for the Home MAN1 samples; these samples
were used in an earlier set of bioassays, so
very little sample remained. UAP standard
reference material 1649 (National Bureau of
Standards, Washington, DC), which consists
of total suspended particulates collected in
the 1970s in Washington, D.C., was selected
as a positive control. We dissolved UAP in
saline solution at 10 mg/mL. All particle sus-
pensions were kept frozen (–20°C) until use. 
We harvested rat alveolar macrophages
(AMs) from two female CD rats (250–300 g
body weight, virus antibody free, Harlan
Sprague Dawley, Inc., Indianapolis, IN) by
bronchoalveolar lavage (BAL) using a phos-
phate-buffered saline (PBS) solution. After
centrifugation, BAL cells were resuspended
at 1 × 106 cells/mL in an assay buffer solu-
tion consisting of RPMI-1640 media
(BioWhittaker, Walkersville, MD) supple-
mented with 1% fetal bovine serum (FBS),
0.1% balanced salt solution, penicillin,
streptomycin, and L-glutamine (RPMI 1%).
For the second set of priming experiments,
AMs were initially treated with a 200 ng/mL
(2,000 EU/mL) solution of bacterial
lipopolysaccharides (Escherichia coli stereo-
type 0127:B8) at 37°C in humid 5% CO2.
Priming was done for 3 hr, and AMs were
subsequently washed and resuspended in
RPMI 1% at 2.4 × 106 cells/mL for use in
the incubations.
Experimental incubations were completed
in Ultra Low Cluster 96-well plates (Costar,
Cambridge, MA), which were prepared
according to manufacturer instructions. We
performed three sets of incubations in dupli-
cate (i.e., for the AMs from the two rats) for
unprimed AMs: a) without particles (negative
controls; n = 4); b) with UAP (positive con-
trols; n = 4); and c) with indoor and outdoor
particles (PM2.5 samples; n = 52). Bioassays
were repeated using primed AMs. We did not
perform the TNF bioassay for either sample
from Home MAN1 due to the extremely low
recoveries. Brieﬂy, we ﬁrst dispensed 80 µL of
assay buffer into each well. Next, we added
80 µL of either concentrated particle suspen-
sion (either indoor/outdoor PM2.5 or UAP)
or assay buffer (negative controls) to each test
well; this was followed by 80 µL of cell sus-
pension. Aliquots of each particle suspension
were previously thawed, probe sonicated, and
diluted so that a standard exposure concen-
tration of 100 µg/mL was attained for each
well. The plates were then incubated for 20
hr in a humidified incubator at 37°C with
5% CO2. Upon completion, the well con-
tents were placed on ice; an aliquot of super-
natant was then removed and stored frozen
for use in the TNF bioassay. 
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Table 1. Sampling locations and dates, and collected and recovered PM2.5.
Starting Sampling Collected mass (µg) Recovery (%)
Home ID Home location Season date duration (days) Indoor Outdoor Indoor Outdoor
MAN1 Manchester-by-the-Sea Winter 13 Feb 1998 7 992.5 249.5 – –
NEW1 Newton Spring 26 Mar 1998 9 1387.5 1,457 22 39
Fall 14 Oct 1998 7 940 828.5 87 74
WEL1 Wellesley Spring 29 Apr 1998 11 2,420 1,568 68 20
Winter 1 Dec 1998 7 1,583 819.5 51 82
SWP1 Swampscott Summer 28 May 1998 8 1427.5 1442.5 56 49
BOX1 Boxford Summer 9 Jun 1998 9 1,074 1211 35 41
Winter 22 Nov 1998 7 397.5 561.5 83 95
NEW2 Newton Summer 20 Jun 1998 6 2,100 2135.5 41 89
Fall 23 Oct 1998 7 679.5 861 88 74
FOX1 Foxboro Summer 7 Jul 1998 9 1273.5 1,317 50 93
Winter 10 Oct 1998 7 579.5 1119.5 61 99
WEL2 Wellesley Winter 5 Nov 1998 7 623.5 977.5 63 85
SWP2 Swampscott Winter 13 Nov 1998 7 812.5 819.5 62 62
Mean ± SE 1,164 ± 56 1,098 ± 126 59 ± 5.5 69 ± 6.9We conducted the TNF bioassay using a
recently published microplate assay (33).
This microplate assay uses a fluorescence-
based quantification technique to assess
TNF-induced cell death in the TNF-sensi-
tive WEHI 164 clone 13 tumor cell line.
Cell cultures were either dosed with AM
supernatants or TNF standards (recombi-
nant rat TNF; R&D Systems, Minneapolis,
MN). We used a Cytofluor fluorescence
plate reader (PerSeptive BioSystems, Inc.,
Framingham, MA) to measure propidium
iodide ﬂuorescence. 
Endotoxin assay. Because other studies
have shown that endotoxin is a potent stim-
ulant of cytokine production (17,23,25,28),
we also measured indoor as well as outdoor
endotoxin concentrations for particle sus-
pensions. Endotoxin was measured by
Limulus assay (chromogenic Limulus amebo-
cyte lysate kit; BioWhittaker) according to
the manufacturer’s instructions. Endotoxin
concentrations are reported as endotoxin
units (EU) per milligram of particles where
10 EU is equivalent to 1 ng of reference
standard endotoxin. Endotoxin was mea-
sured for both whole particle suspensions
and supernatants after centrifugation, but we
report only data for the whole particle sus-
pensions. Whole particle suspensions had
significantly higher endotoxin concentra-
tions than supernatants (2.62 ± 0.67 EU/mg
versus 0.60 ± 0.08 EU/mg). This finding,
which suggests that endotoxin predomi-
nantly exists in a particle-bound form, is
similar to that of a previous study of concen-
trated ambient particles (CAPs) (28). 
Measurement of particulate properties.
As previously described in detail (2), we
used state-of-the-art sampling methodolo-
gies to obtain a rich data set describing
indoor and outdoor particles. We measured
PM2.5 indoors and outdoors using both 12-
hr time-integrated HI samplers and contin-
uous TEOM (tapered element oscillating
microbalance) instruments (Model 1400A;
Rupprecht & Patashnick Co., Inc., Albany
NY). Real-time size distribution measure-
ments were made using two particle sizing
instruments, the scanning mobility particle
sizer (SMPS, Model 3934; TSI, Inc., St.
Paul, MN) and the aerodynamic particle
sizer (APS, Model 3310A; TSI, Inc.). These
instruments provided particle count concen-
trations within discrete size bins between
0.02 and 0.5 µm (SMPS) and 0.7 and 10
µm (APS). As described elsewhere (2,7),
these instruments alternately sampled both
indoor and outdoor air from ports in a spe-
cially designed stainless steel sampling mani-
fold. Size distributions were obtained over
5-min sampling periods; indoor measure-
ments were made at 0, 5, 10, 20, 25, 30, 40,
45, and 50 min after each hour and outdoor
measurements were made at 15, 35, and 55
min after each hour. According to previ-
ously described methods (2), fine particle
SMPS and APS data were converted to vol-
ume concentrations (cubic micrometers per
cubic centimeter) for three particle size
ranges: 0.02–0.1 µm (PV0.02–0.1), 0.1–0.5
µm (PV0.1–0.5), and 0.7–2.5 µm (PV0.7–2.5). 
In addition, 24-hr indoor and outdoor
fine mass samples were collected on quartz
ﬁber ﬁlters for elemental carbon/organic car-
bon (EC/OC) analysis. We used a parallel
plate denuder containing carbon-impregnated
papers for the spring–summer 1998 study
homes to remove vapor-phase organic carbon
before particle collection; use of this denuder
was discontinued after extensive ﬁeld testing
indicated that the denuder efﬁciency was sig-
niﬁcantly < 100% (34). EC/OC samples were
analyzed by thermal/optical reflectance
(TOR) (35) at the Desert Research Institute
(Reno, Nevada). 
Other compositional data collected
include total particle-bound polycyclic aro-
matic hydrocarbons (PAHs). PAHs were
measured continuously using an Ecochem
PAH monitor (Model 1002i; Ecochem
Corporation, West Hills, CA), which sam-
pled in 5-min intervals from the indoor/out-
door manifold. This instrument has been
demonstrated to provide semiquantitative
measurements through the photoelectric ion-
ization of surface-bound PAHs (6,36–38).
The instrument signal was output as a cur-
rent (in units of picoamperes), but was
approximately converted to a concentration
(nanograms per cubic meter) using a univer-
sal conversion factor of 1 µg/m3/pA proposed
by previous studies (36,38).
Other data collected during the compre-
hensive sampling activities include continuous
air exchange rates and detailed time–activity
information. Air exchange rates were mea-
sured in each home every 5 min using a sulfur
hexafluoride tracer gas technique (2,7,39).
This technique employs an SF6 source that
releases the gas into the home at a constant
rate (6 mL/min) and a sensitive photo-
acoustic monitor that continuously measures
the indoor SF6 concentration (Model 3425;
Brüel & Kjær, Nœrum, Denmark). Air
exchange rates were computed using the 5-
min SF6 concentration data, the known
source emission rate, and the home volume
(39). Time–activity information was recorded
by the home occupants in 20-min intervals
using a daily time–activity diary.
Data analysis. We used Version 7 of the
Statistical Analysis System (SAS Institute,
Cary, NC) for all data analyses. Unless other-
wise speciﬁed, all data are reported as means
± SEs. Data are presented as both TNF con-
centrations in picograms per milliliter and as
endotoxin-normalized TNF concentrations
in picograms per endotoxin unit. We com-
puted endotoxin-normalized concentrations,
which represent TNF releases for equivalent
endotoxin levels, because of the well-known
role of endotoxin as a stimulant of cytokine
production (17,23,25,28). We did not use
toxicity data from Home MAN1 in data
analyses because of the absence of bioassay
results. 
We performed the following statistical
analyses: descriptive statistics, nonparamet-
ric hypothesis tests, analysis of variance
(ANOVA), Spearman correlations, and lin-
ear regressions. In all analyses, statistical sig-
nificance was accepted for p-values < 0.05.
We assessed differences between paired
indoor/outdoor samples using a nonparamet-
ric Wilcoxon signed-rank test rather than a
paired t-test because of the small sample size
(n = 26 paired indoor/outdoor samples for
the two rats). A two-way ANOVA analysis
was performed to investigate the between-
sample variability of indoor and outdoor
data. In this analysis, rat was included as a
blocking factor in the model to control for
any variability in the TNF data that was due
to differences in responses between the two
rats. Spearman correlation coefficients were
used to describe the relationship between
indoor and outdoor particle and toxicity
data. Particle data were all averaged over time
periods (e.g., 6–12 days) matching the sam-
pling times of the corresponding toxicity
data. Linear regressions were performed to
investigate the inﬂuence of endotoxin levels
on the observed TNF responses. 
Results
Particle characterization. As shown in Table
2, indoor and outdoor mean PM2.5 concen-
trations for each week-long sampling period
ranged between 4 and 27 µg/m3 and were
moderately correlated (R = 0.51; p = 0.06).
Both indoor and outdoor mean PM2.5 con-
centrations were highest during the July sam-
pling event in Home NEW2 (26.6 and 27.5
µg/m3, respectively). Relatively high mean
indoor concentrations of 17.6 and 17.3 were
also observed during the spring and winter
sampling events in Home WEL1 despite
lower ambient concentrations of 11.3 and 8.4
µg/m3, respectively. As described by Long et
al. (2), large indoor/outdoor differences such
as these are due to the contributions of indoor
source events such as cooking and cleaning
activities. Both indoor and outdoor mean
PV0.1–0.5 and PV0.7–2.5 concentrations were
highly correlated (Spearman R = 0.72 and
0.91; p = 0.004 and < 0.0001, respectively;
Table 2). However, the correlation for the
PV0.02–0.1 data was lower and insigniﬁcant (R
= 0.51; p = 0.06), and in contrast to PV0.1–0.5
and PV0.7–2.5 data, indoor PV0.02–0.1 concen-
trations on average were greater than outdoor
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findings again reflect the impacts of indoor
source events, which have been shown to be
more pronounced for ultraﬁne particles (2). 
As described previously (2), indoor mean
organic carbon concentrations were signifi-
cantly larger than outdoor concentrations
(means of 7.8 and 3.0 µg/m3, respectively),
suggesting that indoor particle events may be
important sources of indoor organic carbon.
Due to the impact of indoor organic carbon
sources, there was very little correlation
between indoor and outdoor concentrations
(R = 0.02; Table 2). In contrast, mean indoor
and outdoor elemental carbon concentrations
were very similar (0.88 and 0.99 µg/m3,
respectively) and highly correlated (R = 0.77;
p = 0.0014). Indoor and outdoor mean PAH
concentrations were also extremely well cor-
related (R = 0.99; p < 0.0001), suggesting
that there were few important indoor PAH
sources in the study homes.
Although not statistically significant,
indoor endotoxin levels were on average
higher than outdoor levels (Figure 1, Tables
2 and 3). The indoor and outdoor mean
endotoxin concentrations were 3.3 ± 1.3 and
2.0 ± 4 EU/mg, respectively. The maximum
endotoxin concentration was 18.1 EU/mg
for the indoor sample from the spring sam-
pling event in Home NEW1, whereas the
corresponding outdoor concentration was
5.0 EU/mg (Table 3). The indoor/outdoor
correlation was low (R = 0.18; p = 0.57) and
the median indoor:outdoor ratio for match-
ing data from each home was 1.5, both sug-
gesting the potential importance of indoor
endotoxin sources. Despite the small num-
ber of samples (n = 13), outdoor endotoxin
concentrations were signiﬁcantly higher (p =
0.007) in the two homes sampled in the
spring, which might be due to elevated plant
emissions during the growing season (40).
Overview of indoor versus outdoor toxicity
responses. Figure 2 shows a comparison of the
TNF release of unprimed AMs for the
indoor and outdoor PM2.5 samples as well as
the negative and positive controls. Table 3
summarizes TNF releases of unprimed AMs
by house and season where data have been
averaged for the two rats. 
We detected TNF only in one of four
negative controls (at 14 pg/mL), whereas TNF
releases for indoor and outdoor samples were
on average > 200 and > 100 pg/mL, respec-
tively. On average, the response of the indoor
samples was just slightly higher than that for
the UAP positive controls (279 ± 78 pg/mL
vs. 270 ± 54 pg/mL). When indoor and out-
door data were normalized for endotoxin lev-
els, the mean indoor response was still nearly
twice as high as the mean outdoor response
(952 ± 157 and 494 ± 96 pg/EU, respec-
tively). The disparity between indoor/outdoor
data remained for the endotoxin-normalized
data despite the fact that normalization for
endotoxin levels changed the relative ranks of
many of the data (Table 3). For example, the
average TNF release for the spring NEW1
indoor sample (1,524 pg/mL) was nearly 3
times greater than the next largest response
for the unadjusted data. After normalization
for endotoxin, it was reduced to a value (840
pg/EU) less than the indoor mean. 
For both the unadjusted and endotoxin-
normalized data, Wilcoxon signed-rank tests
of paired indoor and outdoor samples
showed that indoor TNF releases were sig-
nificantly higher than the corresponding
outdoor data (p = 0.045 and 0.01, respec-
tively). Indoor–outdoor correlations con-
ﬁrmed the poor relationship between indoor
and outdoor data (Figure 3). In contrast to
such particulate properties as elemental car-
bon, PAHs, PV0.1–0.5, and PV0.7–2.5 (Table 2),
there was little correlation between indoor and
outdoor toxicity responses. Nonsignificant
correlations of –0.20 (p = 0.51) were obtained
for both unadjusted and endotoxin-normal-
ized data. As mentioned above, low and
insigniﬁcant correlations were also observed
for organic carbon and endotoxin, each of
which has been demonstrated to have impor-
tant indoor sources (2,40–44). 
As shown by Figures 2 and 3, indoor
TNF releases were also more highly variable
than outdoor TNF releases. A two-way
ANOVA model, which included rat as a
blocking factor to control for variability in
TNF releases among individual rats, was used
to statistically test the sample-to-sample vari-
ability of indoor and outdoor samples.
Although several homes were sampled twice
in different seasons, each sample was treated
as an independent sample because ambient
and home conditions differed between the
two sampling seasons in the same home.
Despite the small sample size, the variability
of both the indoor-unadjusted and endo-
toxin-normalized data was found to be statis-
tically significant (p < 0.0001 and 0.04,
respectively). However, for both sets of out-
door data, the between-sample variability was
insigniﬁcant (p=0.27 and 0.49 for the unad-
justed and endotoxin-normalized data,
respectively). These ﬁndings for the outdoor
data suggest that the significant indoor
between-sample variability is not due to dif-
ferences in ambient particle toxicity. Instead,
given that each bioassay was conducted for
the same particle concentration (100 µg/mL),
differences in indoor particle properties such
as composition are likely responsible for the
observed indoor between-sample variability. 
Similar to previous studies (23,29), TNF
production was significantly elevated for
lipopolysaccharide-primed cells, both for
negative controls as well as for particle sus-
pensions (data not shown). For the negative
controls, priming elicited a mean response of
1,302 ± 349 pg/mL, which is three orders of
magnitude higher than that for the unprimed
controls. The priming effect was even more
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Table 2. Summary statistics for indoor/outdoor particulate data.a
Indoor/outdoor 
Particulate concentration data correlations
Parameter No. Location Mean ± SE Min Median Max Spearman Rp -Value
PM2.5 14 In 11.8 ± 1.9 5.7 10.7 26.6 0.51 0.06
(µg/m3) Out 11.1 ± 1.5 4.1 10.3 27.5
PV0.02–0.1 14 In 0.68 ± 0.10 0.18 0.54 1.4 0.51 0.06
(µm3/cm3) Out 0.48 ± 0.05 0.23 0.49 0.85
PV0.1–0.5 14 In 6.2 ± 0.90 1.7 6.2 14.7 0.72 0.004
(µm3/cm3) Out 6.3 ± 0.94 2.1 5.8 15.0
PV0.7–2.5 13b In 2.3 ± 0.45 0.85 1.9 6.5 0.91 < 0.0001
(µm3/cm3) Out 2.7 ± 0.49 1.1 2.0 8.0
EC (µg/m3)1 4I n 0.88 ± 0.09 0.35 0.90 1.5 0.77 0.0014
Out 0.99 ± 0.10 0.47 0.96 1.6
OC (µg/m3)1 4I n7.8 ± 0.57 4.7 7.8 13.6 0.02 0.95
Out 3.0 ± 0.19 1.4 3.2 4.2
PAH (ng/m3)1 4I n 31 ± 5.6 4.2 25 82 0.99 < 0.0001
Out 37 ± 7.7 5.6 27 107
Endotoxin 13c In 3.3 ± 1.3 0.51 2.2 18.1 0.18 0.57
(EU/mg) Out 2.0 ± 0.41 0.36 1.5 5.0
Abbreviations: EC, elemental carbon; Max, maximum; Min, minimum; OC, organic carbon.
aAll concentrations and correlations are for data that have been averaged over the duration of the sampling period within
a home to match the sampling duration of the corresponding toxicity samples. bPV0.7-2.5 data are not available for the
spring sampling event in Home NEW1 due to instrument failure. cEndotoxin data are not reported for Home MAN1 due to
extremely low sample recoveries (see text). 
Figure 1. Box plots comparing outdoor and indoor
endotoxin levels. 
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5%ampliﬁed in the presence of particles, as the
average indoor and outdoor primed responses
were over 3,500 and 2,500 pg/mL, respec-
tively. These results demonstrate the enhanced
sensitivity of primed cells to both indoor and
outdoor ﬁne particles, which has been shown
previously for CAP samples (23,29). Given
the similarity of the indoor/outdoor relation-
ship for the unprimed and primed data, our
focus for the remainder of this paper is on the
unprimed bioassay data.
Evidence of endotoxin-induced TNF
production. Figure 4A and B shows the rela-
tionship between endotoxin concentrations
and TNF responses for the indoor and out-
door data. These plots show that endotoxin
levels were strongly associated with TNF
responses for both indoor and outdoor ﬁne
particle data. The indoor regression was per-
formed with and without the extreme data
point for the spring Home NEW1 sample.
This sample yielded the highest endotoxin
concentration (18.1 EU/mg) as well as the
highest mean TNF responses for both
unprimed and primed AMs (over 1,500 and
15,000 pg/mL, respectively). Despite the
fact that this data point highly influenced
the model ﬁt (as indicated by the R2 values
of 0.92 and 0.40 with and without this data
point, respectively), it did not bias the ﬁtted
slope which just slightly dropped from 84 to
82 when the data point was removed. 
Although endotoxin levels explained a
similar level of variability in TNF releases for
both indoor and outdoor data (R2 values
were both approximately 0.40 when the
indoor NEW1 data were excluded), the
regression slopes differed for the two sets of
data. As mentioned above, the indoor slope
was approximately 80; however, the outdoor
slope was only 49. The difference between
the two slopes suggests that the magnitude
of the endotoxin-mediated toxicity response
may depend on other particle properties.
The synergistic interactions between endo-
toxin and other proinflammatory compo-
nents of environmental particles have been
previously hypothesized (23,28). In a series
of bioassay experiments, Imrich et al. (23)
demonstrated that there was no difference in
TNF release between primed cells treated
with saline (control) or with inert TiO2 par-
ticles. However, TNF releases were highly
amplified when primed cells were treated
with CAPs (23). Furthermore, Ning et al.
(28) showed that particle-associated endo-
toxin in CAP samples elicits much greater
bioactivity than the same amount of soluble
endotoxin given to AMs alone. For this
study, the larger indoor slope suggests that
there is greater synergism between endotoxin
and components of indoor particles.
Inﬂuence of air exchange rate on indoor
particle toxicity. Figure 5A and B shows that
higher indoor TNF releases and indoor/out-
door differences in TNF releases were typically
observed in homes with lower air exchange
rates, particularly for the endotoxin-normal-
ized data. Air exchange rates were classiﬁed as
either high or low on the basis of whether they
were above or below the median home air
exchange rate of 0.84/hr. Despite the small
sample size, both indoor endotoxin-normal-
ized TNF releases, as well as the difference
between indoor/outdoor endotoxin-normal-
ized TNF releases, were signiﬁcantly higher for
the low air exchange rate class (p = 0.005 for
both). Similar Wilcoxon ranked-sum tests of
the unadjusted data yielded insigniﬁcant p-val-
ues of 0.23 and 0.14, respectively. These ﬁnd-
ings, together with evidence that the impacts
of indoor source events are even more pro-
nounced at low air exchange rates when
indoor residence times are longer and indoor-
generated particles can accumulate (2,7,45),
suggest that the higher indoor toxicity
responses may be due to the effects of indoor-
generated particles. 
Estimation of indoor toxicity compo-
nents. We constructed a simple physical–sta-
tistical model to quantify the relative
contributions of indoor-generated and ambi-
ent particles to the indoor toxicity response.
This model assumes that the endotoxin-nor-
malized indoor toxicity response (Tox´in in
picograms per endotoxin unit) is a function
of the fraction of particles of indoor origin
(Fin) and those of ambient origin (Fa): 
Tox´in= αinFin + αaFa, (1)
where αin and αa (both in picograms per
endotoxin unit) represent the portions of the
indoor toxicity response that can be attrib-
uted to particles of indoor origin and those of
ambient origin, respectively. This model is
based on the fact that each bioassay was con-
ducted for a uniform exposure concentration
of 100 µg/mL, thus effectively removing any
relationship with particle concentration. We
also assumed that Fin and Fa represent the
fraction of indoor-generated and ambient
particles, respectively, in the 100 µg/mL par-
ticle suspensions. We used endotoxin-nor-
malized data in the model because we
hypothesized that there are synergistic inter-
actions between particles and endotoxin
which depend on particle properties.
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Table 3. Summary of PM2.5 endotoxin and toxicity data by house and season.
Endotoxin concentration TNF releasea
(EU/mg) Unadjusted (pg/mL) Normalized (pg/EU)
Home ID Season Indoor Outdoor Indoor Outdoor Indoor Outdoor
MAN1 Winter — — — — — —
NEW1 Spring 18.135 4.989 1,524 64 840 127
Fall 2.018 1.463 221 41 1,093 277
WEL1 Spring 1.049 4.477 55 389 520 869
Winter 1.304 0.937 218 18 1,668 192
SWP1 Summer 2.465 2.861 71 87 288 302
BOX1 Summer 4.737 0.648 558 25 1,177 378
Winter 2.896 2.182 135 209 466 958
NEW2 Summer 0.819 0.355 26 7 318 197
Fall 2.998 2.056 37 257 123 1,250
FOX1 Summer 1.368 0.678 101 18 735 258
Winter 2.179 0.698 324 37 1,485 530
WEL2 Winter 0.511 2.748 134 178 2,613 646
SWP2 Winter 2.16 1.355 227 60 1,051 443
Mean ± SE 3.3 ± 1.3 2.0 ± 0.1 279 ± 111 107 ± 32 952 ± 190 494 ± 95
aData are mean values for test results for two rats.
Figure 2. TNF production of unprimed AMs in negative controls (n = 4), positive controls (UAP; n = 4), and
indoor (n = 26) and outdoor (n = 26) PM2.5 samples. (A) Unadjusted TNF data. (B) Endotoxin-normalized
TNF data.
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0Because Fa = 1 – Fin, Equation 1 is sim-
ply equal to the following:
Tox´in = αinFin + αa (1 – Fin) (2)
After rearranging terms, the following equa-
tion is obtained:
Tox´in =(αin – αa) Fin + αa (3)
If Tox´in is regressed on Fin, the slope (e.g.,
αin – αa) approximates the difference
between the mean endotoxin-normalized
TNF response attributable to indoor-gener-
ated particles and that for indoor particles of
ambient origin, whereas the intercept (e.g.,
αa) represents the mean response due to
indoor particles of ambient origin. 
We calculated model values for Fin for
these study homes using previously reported
estimates of ambient particle inﬁltration fac-
tors (FINF) (46). Infiltration factors, which
ranged from 0.40 to 1.09, were estimated
from simultaneous indoor/outdoor PM2.5
data from nighttime, nonsource periods for
all but the spring sampling events in Homes
WEL1 and NEW1 (46). Nightly FINF esti-
mates were averaged over the entire sampling
duration within a home to match the averag-
ing period of the toxicity data. For the
spring sampling events in Homes WEL1 and
NEW1, where matching indoor/outdoor
continuous PM2.5 measurements were not
available, SMPS and APS particle volume
data were summed to approximate PV2.5.
The indoor concentration of ambient fine
particles (Ca) was first quantified by multi-
plying the inﬁltration factor by the outdoor
PM2.5 concentration (Cout):
Ca = FINF × Cout (4)
It was then possible to estimate the indoor
fraction of ambient particles
(5)
and the corresponding indoor fraction of
indoor-generated particles
Fin  = 1 – Fa (6)
Estimates of Fin ranged from a low of approx-
imately 0 for the summer sampling events in
Homes SWP1, BOX1, and NEW1 to a high
of 0.74 for the winter sampling event in
Home WEL1 (0.28 ± 0.06, mean ± SE).
Model results presented in Figure 6A and
B suggest the enhanced bioactivity of indoor-
generated particles. Despite the small data
set, we found a strong and near-significant
relationship (R2=0.29; p = 0.06) between the
endotoxin-normalized TNF release and Fin
(Figure 6A). Furthermore, the intercept of
491 ± 275 pg/EU, which represents the
mean endotoxin-normalized TNF response
attributable to indoor particles of ambient
origin, was very close to the outdoor mean
TNF release of 494 ± 96 pg/EU. In contrast,
the estimate for the mean endotoxin-normal-
ized TNF response attributable to indoor-
generated particles was approximately 2,100
± 600 pg/EU (Figure 6B).
Discussion
Rat AMs treated with either indoor or out-
door PM2.5 released significant amounts of
TNF compared to control AMs. Furthermore,
these TNF releases for both indoor and out-
door PM2.5 samples are of similar magnitude
to that observed for CAPs by other investiga-
tors. Speciﬁcally, Imrich et al. (23) observed
mean TNF releases of 10–130 pg/mL for rat
AMs exposed to 100 µg/mL CAPs from sev-
eral daily samples, and 20–260 pg/mL for
human alveolar macrophages exposed to 50
µg/mL CAP suspensions. In addition, TNF
production was further ampliﬁed for primed
AMs exposed to these indoor and outdoor
PM2.5 samples. This priming effect is com-
parable to that observed by a previous study
of rat and human AMs exposed to CAPs or
UAP (23). These results suggest that indoor
PM2.5 may also have a synergistic effect on
the inflammatory response in people with
preexisting proinﬂammatory conditions. 
A comparison of paired indoor/outdoor
data demonstrated that significantly greater
TNF releases were elicited by indoor PM2.5
samples than by the corresponding outdoor
samples. The signiﬁcance of this indoor/out-
door difference slightly increased when data
were normalized for endotoxin concentra-
tions. This ﬁnding alone suggests that indoor
particles are at least as toxic as outdoor parti-
cles. As described earlier, indoor particles
include particles of both ambient and indoor
origin. Together with this indoor/outdoor
difference, other study ﬁndings suggest that
particles of indoor origin may be more bioac-
tive than particles of ambient origin. 
The role of indoor-generated particles in
indoor particle bioactivity is supported by
several study findings. Specifically, the low
indoor/outdoor correlation between paired
toxicity data is suggestive of the impact of
indoor-generated particles. Also, regressions
of TNF releases on endotoxin concentra-
tions yielded steeper slopes for indoor than
outdoor data, suggesting that there may be
greater synergism between endotoxin and
components of indoor particles. In addition,
indoor but not outdoor TNF releases were
   
F
C
C
a
a
in
=
Articles • Long et al.
1024 VOLUME 109 | NUMBER 10 | October 2001 • Environmental Health Perspectives
Figure 4. Linear regressions of TNF release versus endotoxin concentration for (A) indoor data [regres-
sion output: slope = 84 (p < 0.01);r2 = 0.92; without extreme data point: slope = 82 (p = 0.03); r2 = 0.40)] and
(B) outdoor data [regression output: slope = 49 (p = 0.02);r2 = 0.38].
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Figure 3. Indoor versus outdoor TNF releases for (A) unadjusted data (Spearman R = –0.20; p = 0.51; n = 13)
and (B) endotoxin-normalized data (Spearman R = –0.20; p = 0.51; n = 13). Each data point represents data
from one sampling event in which TNF releases have been averaged over the two rats (n = 13).
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Outdoor endotoxin-normalized TNF (pg/EU)shown to exhibit signiﬁcant between-sample
variability. Due to the use of a uniform expo-
sure concentration of 100 µg/mL, the vari-
ability in indoor TNF releases may be
attributed to ﬂuctuations in particle proper-
ties (e.g., composition, size ) among the
indoor samples. The contributions of indoor
source events have been previously shown to
be a dominant source of variability for indoor
particle concentrations and size distributions
(2,7). Furthermore, it has been previously
reported that source strengths of indoor par-
ticle events were highly variable in these
study homes (2). If differences in indoor
source types and event frequency among the
study homes are also considered, it is likely
that variability in indoor particle emission
rates, as well as particle characteristics among
the study homes, may explain the variability
in indoor TNF releases.
It has also been reported that the impacts
of indoor particle events are ampliﬁed under
conditions of low air exchange rate (2,7,45).
Results from the present study have shown
that the level of indoor bioactivity and the
difference between indoor and outdoor
bioactivities depend on air exchange rate.
The five largest indoor/outdoor differences
in the endotoxin-normalized TNF release
occurred for homes with lower exchange
rates (i.e., below the study median), suggest-
ing that the indoor toxicity response is
amplified when air exchange rates are low
and indoor residence times are high. During
low air exchange rate conditions, indoor par-
ticle events can dramatically increase the
fraction of indoor particles of indoor origin
as concentrations of indoor-generated parti-
cles build up. In addition, low air exchange
rates are also associated with decreased ambi-
ent particle infiltration (46–49), which
results in diminished indoor concentrations
of ambient particles. Thus, it would appear
that conditions which favor the accumula-
tion of indoor-generated particles rather
than ambient particles may thus raise the
toxicity of indoor particles.
Despite the small sample size, the results
of our simple physical–statistical model con-
ﬁrm that indoor particle toxicity may be ele-
vated as the fraction of indoor-generated
particles increases. This model demonstrated
that differences in the indoor toxicity response
between samples could be explained by the
fractions of particles of indoor and ambient
origin. The mean endotoxin-normalized TNF
response attributable to particles of indoor
origin was over four times higher than the
corresponding estimate for particles of ambi-
ent origin (2,100 ± 600 pg/EU versus 491 ±
275 pg/EU).
It is still unclear which components of
indoor-generated particles may be responsi-
ble for their enhanced bioactivity. In this
study we have confirmed the role of endo-
toxin as a stimulant of cytokine production
(17,23,25,28). However, endotoxin levels
were not found to differ significantly
between indoor and outdoor fine particles.
In addition, normalization for endotoxin did
not eliminate the variability in the indoor
TNF data, suggesting that there are other
proinﬂammatory components of indoor par-
ticles. Based on in vitro experiments employ-
ing endotoxin inhibitors, other investigators
have hypothesized that there are other proin-
ﬂammatory components of ambient particles
(28,29). One possible proinflammatory
component for indoor particles may be
organic carbon, which was present in signiﬁ-
cantly higher concentrations in indoor
PM2.5 samples. Organic carbon is known to
be enriched in fine particles, and previous
studies have demonstrated the mutagenic
(50–52) and carcinogenic (53) properties of
airborne particulate-bound carbon. 
Although these results are suggestive, cau-
tion must be exercised in interpreting them.
The implications of these results with respect
to in vivo effects are very uncertain. In vitro
exposure conditions are clearly not represen-
tative of particle inhalation and deposition in
the lungs. In addition, although TNF is
known to initiate the inflammatory activa-
tion of AMs, it is unclear whether the differ-
ences in TNF release for indoor versus
outdoor PM2.5 would result in different in
vivo toxic effects. Furthermore, these study
ﬁndings are also based on a small sample size.
PM2.5 samples were collected from only nine
homes and represent very small periods of
time in these homes (e.g., 1–2 weeks). 
The intent of this study was to explore
the relative toxicities of indoor and outdoor
ﬁne particles. These study ﬁndings indicate
that particles of indoor origin can induce
cytokine production, and they point to the
need for additional efforts to understand
indoor exposures to both particles of indoor
origin as well as those of ambient origin.
Given the large amounts of time that people
spend indoors, these study findings suggest
that indoor particles should be the focus of
further toxicologic research.
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